249 related articles for article (PubMed ID: 23763383)
1. DICER1 exons 25 and 26 mutations are rare in common human tumours besides Sertoli-Leydig cell tumour.
Kim MS; Lee SH; Yoo NJ; Lee SH
Histopathology; 2013 Sep; 63(3):436-8. PubMed ID: 23763383
[No Abstract] [Full Text] [Related]
2. Distinct somatic DICER1 hotspot mutations in three metachronous ovarian Sertoli-Leydig cell tumors in a patient with DICER1 syndrome.
Garcia A; Desrosiers L; Scollon S; Gruner S; Reuther J; Gandhi I; Patil N; Fuller MY; Dai H; Muzny D; Gibbs RA; Bercaw-Pratt JL; Rao SL; Rainusso N; Fisher KE; Lin FY; Plon SE; Parsons DW; Roy A
Cancer Genet; 2022 Apr; 262-263():53-56. PubMed ID: 35026696
[No Abstract] [Full Text] [Related]
3. Functional characterization of multiple DICER1 mutations in an adolescent.
Wu MK; de Kock L; Conwell LS; Stewart CJ; King BR; Choong CS; Hussain K; Sabbaghian N; MacRae IJ; Fabian MR; Foulkes WD
Endocr Relat Cancer; 2016 Feb; 23(2):L1-5. PubMed ID: 26545620
[No Abstract] [Full Text] [Related]
4. A family with Sertoli-Leydig cell tumour, multinodular goiter, and
Haley M; Bindal P; McAuliffe A; Vredenburgh J
Curr Oncol; 2019 Jun; 26(3):183-185. PubMed ID: 31285663
[TBL] [Abstract][Full Text] [Related]
5. DICER1 hotspot mutations in ovarian Sertoli-Leydig cell tumors: a potential association with androgenic effects.
Kato N; Kusumi T; Kamataki A; Tsunoda R; Fukase M; Kurose A
Hum Pathol; 2017 Jan; 59():41-47. PubMed ID: 27664536
[TBL] [Abstract][Full Text] [Related]
6. Lessons from genomic profiling: towards a molecular-based classification of ovarian Sertoli-Leydig cell tumour.
Kommoss FKF
Histopathology; 2024 Mar; 84(4):712-714. PubMed ID: 38114269
[TBL] [Abstract][Full Text] [Related]
7. The co-occurrence of an ovarian Sertoli-Leydig cell tumor with a thyroid carcinoma is highly suggestive of a DICER1 syndrome.
Durieux E; Descotes F; Mauduit C; Decaussin M; Guyetant S; Devouassoux-Shisheboran M
Virchows Arch; 2016 May; 468(5):631-6. PubMed ID: 26983701
[TBL] [Abstract][Full Text] [Related]
8. DICER1 and FOXL2 mutations in ovarian sex cord-stromal tumours: a GINECO Group study.
Goulvent T; Ray-Coquard I; Borel S; Haddad V; Devouassoux-Shisheboran M; Vacher-Lavenu MC; Pujade-Laurraine E; Savina A; Maillet D; Gillet G; Treilleux I; Rimokh R
Histopathology; 2016 Jan; 68(2):279-85. PubMed ID: 26033501
[TBL] [Abstract][Full Text] [Related]
9. Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers.
Heravi-Moussavi A; Anglesio MS; Cheng SW; Senz J; Yang W; Prentice L; Fejes AP; Chow C; Tone A; Kalloger SE; Hamel N; Roth A; Ha G; Wan AN; Maines-Bandiera S; Salamanca C; Pasini B; Clarke BA; Lee AF; Lee CH; Zhao C; Young RH; Aparicio SA; Sorensen PH; Woo MM; Boyd N; Jones SJ; Hirst M; Marra MA; Gilks B; Shah SP; Foulkes WD; Morin GB; Huntsman DG
N Engl J Med; 2012 Jan; 366(3):234-42. PubMed ID: 22187960
[TBL] [Abstract][Full Text] [Related]
10. DICER1-related Sertoli-Leydig cell tumor and gynandroblastoma: Clinical and genetic findings from the International Ovarian and Testicular Stromal Tumor Registry.
Schultz KAP; Harris AK; Finch M; Dehner LP; Brown JB; Gershenson DM; Young RH; Field A; Yu W; Turner J; Cost NG; Schneider DT; Stewart DR; Frazier AL; Messinger Y; Hill DA
Gynecol Oncol; 2017 Dec; 147(3):521-527. PubMed ID: 29037807
[TBL] [Abstract][Full Text] [Related]
11. Testicular Sertoli cell tumour and potentially testicular Leydig cell tumour are features of
Golmard L; Vasta LM; Duflos V; Corsini C; Dubois d'Enghien C; McMaster ML; Harney LA; Carr AG; Ling A; Dijoud F; Gauthier A; Miettinen M; Cost NG; Gauthier-Villars M; Orbach D; Irtan S; Haouy S; Schultz KA; Stoppa-Lyonnet D; Coupier I; Stewart DR; Sirvent N
J Med Genet; 2022 Apr; 59(4):346-350. PubMed ID: 33782093
[No Abstract] [Full Text] [Related]
12. DICER1 and FOXL2 Mutation Status Correlates With Clinicopathologic Features in Ovarian Sertoli-Leydig Cell Tumors.
Karnezis AN; Wang Y; Keul J; Tessier-Cloutier B; Magrill J; Kommoss S; Senz J; Yang W; Proctor L; Schmidt D; Clement PB; Gilks CB; Huntsman DG; Kommoss F
Am J Surg Pathol; 2019 May; 43(5):628-638. PubMed ID: 30986800
[TBL] [Abstract][Full Text] [Related]
13. Mutiple DICER1-related lesions associated with a germline deep intronic mutation.
Verrier F; Dubois d'Enghien C; Gauthier-Villars M; Bonadona V; Faure-Conter C; Dijoud F; Stoppa-Lyonnet D; Houdayer C; Golmard L
Pediatr Blood Cancer; 2018 Jun; 65(6):e27005. PubMed ID: 29469200
[TBL] [Abstract][Full Text] [Related]
14. Somatic tumour testing establishes that bilateral DICER1-associated ovarian Sertoli-Leydig cell tumours represent independent primary neoplasms.
McCluggage WG; Chong AL; de Kock L; Foulkes WD
Histopathology; 2020 Aug; 77(2):223-230. PubMed ID: 32333409
[TBL] [Abstract][Full Text] [Related]
15. Gynecologic Manifestations of the DICER1 Syndrome.
Stewart CJ; Charles A; Foulkes WD
Surg Pathol Clin; 2016 Jun; 9(2):227-41. PubMed ID: 27241106
[TBL] [Abstract][Full Text] [Related]
16. Moderately differentiated Sertoli-Leydig cell tumour: a hormone-secreting neoplasm associated with DICER1 syndrome.
Khan S; Hodgson A
Int J Gynecol Cancer; 2023 Dec; 33(12):1981-1982. PubMed ID: 37543372
[No Abstract] [Full Text] [Related]
17. The oncogenic roles of DICER1 RNase IIIb domain mutations in ovarian Sertoli-Leydig cell tumors.
Wang Y; Chen J; Yang W; Mo F; Senz J; Yap D; Anglesio MS; Gilks B; Morin GB; Huntsman DG
Neoplasia; 2015 Aug; 17(8):650-60. PubMed ID: 26408257
[TBL] [Abstract][Full Text] [Related]
18. DICER1 Mutation in Recurrent Ovarian Sertoli-Leydig Cell Tumor: A Case Report.
Liu S; Pokoradi AJ; Soboleski D; Childs T; Agrawal A
J Pediatr Adolesc Gynecol; 2023 Apr; 36(2):107-111. PubMed ID: 36402443
[TBL] [Abstract][Full Text] [Related]
19. Ovarian Sertoli-Leydig Cell Tumor with Elevated Inhibin B as a Cause of Secondary Amenorrhea in an Adolescent with Germ Line DICER1 Mutation.
Luke AM; Moroney JW; Snitchler A; Whiteway SL
J Pediatr Adolesc Gynecol; 2017 Oct; 30(5):598-600. PubMed ID: 28502826
[TBL] [Abstract][Full Text] [Related]
20. Sertoli-Leydig cell tumor in two siblings with DICER1 syndrome: A case report and literature review.
Zhang Y; Ren M; Hong Y; Zhong Y; Cong X; Chen C; Liu Z; Man Y; Yang L
Medicine (Baltimore); 2020 Jul; 99(27):e20806. PubMed ID: 32629665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
